BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.73
-0.56 (-2.76%)
At close: Mar 9, 2026, 4:00 PM EDT
19.73
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
BioAge Labs Stock Forecast
Stock Price Forecast
The 5 analysts that cover BioAge Labs stock have a consensus rating of "Buy" and an average price target of $44.4, which forecasts a 125.04% increase in the stock price over the next year. The lowest target is $12 and the highest is $73.
Price Target: $44.4 (+125.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioAge Labs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Hold | 3 | 2 | 2 | 3 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $60 | Buy | Initiates | $60 | +204.11% | Feb 25, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $9 → $62 | Hold → Strong Buy | Upgrades | $9 → $62 | +214.24% | Feb 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $73 | Buy | Initiates | $73 | +269.99% | Jan 27, 2026 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $5 → $12 | Sell → Hold | Upgrades | $5 → $12 | -39.18% | Dec 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | -23.97% | Oct 29, 2025 |
Financial Forecast
Revenue This Year
7.26M
Revenue Next Year
72.46M
from 7.26M
Increased by 898.47%
EPS This Year
-2.31
from -6.63
EPS Next Year
-2.76
from -2.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.0M | 498.8M | ||||
| Avg | 7.3M | 72.5M | ||||
| Low | 5.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 6,772.7% | ||||
| Avg | - | 898.5% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.17 | -2.19 | |||
| Avg | -2.31 | -2.76 | |||
| Low | -2.67 | -3.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.